You can buy or sell Gamida Cel and other stocks, options, ETFs, and crypto commission-free!
Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Read More Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City
BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (GMDA), a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming healthcare conferences taking place in New York City during May. On Thursday, May 16, 2019, members of Gamida Cell’s management team will participate in investor meetings at the Oppenheimer & Co. Oncology Insight Summit. Additionally, Julian Adams, Ph.D., chief executive officer of Gamida Cell, will participate in a “fireside chat” at the...
Yahoo FinanceApr 30
Gamida Cell Announces the Date of Its First Quarter 2019 Financial Results and Webcast
BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (GMDA), a leading cellular and immune therapeutics company, today announced that the company will host a conference call and live audio webcast on Tuesday, May 7, 2019, at 8:30 a.m. ET to review its first quarter 2019 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the “Investors” section of Gamida Cell’s website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (dome...
-$0.37 per share
-$0.62 per share